RxDoctor Payments Data

Ana Wiley

Adult Health · Richmond, VANPI 1750803961

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $922, 5.0 times the $184 reported in 2021.

$3,601in general payments, 2019–2025

Across 150 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$683
  • Sanofi$449
  • AbbVie$364
  • Regeneron Healthcare Solutions, Inc.$331
  • Incyte Corporation$304
  • Johnson & Johnson$283
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,584100%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,601 in reported general payments places this provider in the 85th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$61,148
Medicare patients
212
Services billed
893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab16$62,866
Clobetasol Propionate75$5,864
Pimecrolimus19$5,168
Ketoconazole81$1,597
Clindamycin Phosphate37$1,036
Tretinoin12$851
Metronidazole13$684
Triamcinolone Acetonide44$397
Doxycycline Hyclate22$359
Fluocinonide11$351
Hydrocortisone15$86
Mupirocin16$84

Paid to pharmacies, not to this prescriber.

Other adult health in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →